Evidence map›Paper›PMID 41552371›Full record

ArticleJournal of proteomics and genomics research2025

Plasma TREM2 levels, alcohol consumption, and liver enzymes in patients with alcohol use disorder: a sex-dependent relationship involving MS4A6A genetic polymorphism.

Ming-Fen Ho, Cheng Zhang, Brandon Coombes, Joanna Biernacka, Michelle Skime, Paul E Croarkin, Tyler Oesterle, Victor M Karpyak, Hu Li, Richard Weinshilboum

Abstract read
In one paragraph

Article in Journal of proteomics and genomics research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ming-Fen HoDepartment of Psychiatry and Psychology, Mayo Clinic; Rochester, Minnesota, USA.
Cheng ZhangDepartment of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, Minnesota, USA.
Brandon CoombesDivision of Computational Biology, Quantitative Health Sciences; Mayo Clinic; Rochester, Minnesota, USA.
Joanna BiernackaDivision of Computational Biology, Quantitative Health Sciences; Mayo Clinic; Rochester, Minnesota, USA.
Michelle SkimeDepartment of Psychiatry and Psychology, Mayo Clinic; Rochester, Minnesota, USA.
Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic; Rochester, Minnesota, USA.
Tyler OesterleDepartment of Psychiatry and Psychology, Mayo Clinic; Rochester, Minnesota, USA.
Victor M KarpyakDepartment of Psychiatry and Psychology, Mayo Clinic; Rochester, Minnesota, USA.
Hu LiDepartment of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, Minnesota, USA.
Richard WeinshilboumDepartment of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, Minnesota, USA.

Funding

Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed PharmacogenomicsR01AA027486 · NIAAA · MAYO CLINIC ROCHESTER · PI Ming-Fen Ho, Richard M. Weinshilboum · 2018 to 2026
$4.0M
The Mayo Clinic Center for Individualized Treatment of Alcohol DependenceP20AA017830 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2010
$2.5M
Single cell multi-omics of iPSC-derived brain organoids from patients with opioid use disorder: synthetic opioids as molecular probesR01DA057928 · NIDA · MAYO CLINIC ROCHESTER · PI Ming-Fen Ho · 2023 to 2026
$1.7M
Acamprosate pharmacogenomics: iPSC based model of alcohol use disorderK01AA028050 · NIAAA · MAYO CLINIC ROCHESTER · PI HO, MING-FEN · 2019 to 2024
$649k
NIAAA NIH HHS K01 AA028050NIAAA NIH HHS P20 AA017830NIAAA NIH HHS R01 AA027486NIDA NIH HHS R01 DA057928
6 · The paper itself

Abstract

Alcohol use disorder (AUD) is the most prevalent substance use disorder. Excessive alcohol consumption leads to a range of health issues. We set out to identify inflammatory markers linked to alcohol consumption, which might ultimately offer novel insight into genetic underpinnings and have implications for alcohol-associated disease. Alcohol consumption and blood-based multi-omics data were collected by The Mayo Clinic Center for Individualized Treatment of Alcohol Dependence study. Plasma samples from patients with AUD were used for proteomics analysis using the OLINK "Explore Inflammation" panel (n=410). Liver enzymes were also measured. A genome-wide association study (GWAS) was performed to explore the relationship between genetic variants and plasma TREM2 levels. Our findings show that plasma triggering receptor expressed on myeloid cells 2 (TREM2), a key gene associated with neurodegenerative disease, was the most significant signal correlated with alcohol consumption, and has also been associated with liver enzyme levels in patients with AUD. We identified the rs7232 single nucleotide polymorphism (SNP) in

Indexed as

alcohol consumptiongenetic polymorphism and plasma proteomicsMS4A6ATREM2

Identifiers

PMID41552371
PMCPMC12810868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.